A 3-period, 7-day Dosing (Per Period) Study to Explore the Safety and Efficacy of JNJ-40929837 in Patients With Mild Asthma Following an Asthma-inducing Allergen Challenge.
This study has been completed.
Study NCT01241422
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on October 25, 2010.
Last Updated on May 25, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
